Vantage logo

To buy or build blockbusters?

A look at blockbuster origins shows the role of external innovation, but more of these huge franchises are in the hands of their inventors than ever before.

Vantage logo

The patent winter is coming

Biopharma is approaching the most painful period of patent loss for at least 30 years. Is M&A an answer?

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.